Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Total Current Liabilities (2021 - 2024)

Opus Genetics (IRD) has disclosed Total Current Liabilities for 3 consecutive years, with $3.9 million as the latest value for Q3 2023.

  • On a quarterly basis, Total Current Liabilities rose 45.26% to $3.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was $3.9 million, a 45.26% increase, with the full-year FY2022 number at $2.8 million, down 28.59% from a year prior.
  • Total Current Liabilities was $3.9 million for Q3 2023 at Opus Genetics, down from $5.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $5.8 million in Q2 2023 to a low of $2.3 million in Q1 2021.
  • A 3-year average of $3.4 million and a median of $3.2 million in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: dropped 28.59% in 2022, then skyrocketed 74.36% in 2023.
  • Opus Genetics' Total Current Liabilities stood at $3.9 million in 2021, then decreased by 28.59% to $2.8 million in 2022, then skyrocketed by 41.99% to $3.9 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Total Current Liabilities are $3.9 million (Q3 2023), $5.8 million (Q2 2023), and $4.2 million (Q1 2023).